A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II
Status:
Not yet recruiting
Trial end date:
2022-09-19
Target enrollment:
Participant gender:
Summary
In this study, the study drug 'NNC0385-0434' will be tested in 3 different tablet
formulations. These formulations are being tested for the treatment of hypercholesterolemia
(high cholesterol). Participants will only receive 2 of the 3 tablet formulations. The
treatments participants get are decided by chance. Participants will receive 1 formulation
for 10 days (first treatment period) and the other formulation for 5 days (second treatment
period). The study will last up to 96 days. Only men can participate in this clinical study.